Loading...

Fixation Buffer Fixation Buffer

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixative, Paraformaldehyde
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420801 100 mL DKK351
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Fixation Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Fixation Buffer is used to fix cells prior to permeabilization using Permeabilization Wash Buffer (Cat. No. 421002). BioLegend's Fixation Buffer has been formulated with prescreened paraformaldehyde with low background, thus producing the greatest signal to noise ratio.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
This buffer solution should be stored between 2°C and 8°C.
Application

ICFC - Quality tested
ICC
Recommended Usage

For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website.
Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.

Application Notes

This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.

Application References
  1. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  2. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed
  3. Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed
  4. del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed
  5. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  6. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  7. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  8. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
Product Citations
  1. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  2. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  3. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  4. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  5. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  6. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  7. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  8. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  9. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  10. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  11. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  12. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  13. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  14. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  15. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  16. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  17. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  18. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  19. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  20. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  21. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  22. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  23. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  24. Chan L, et al. 2022. Cells. 12: . PubMed
  25. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  26. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  27. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  28. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  29. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  30. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  31. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  32. Zander R, et al. 2022. Immunity. 55:475. PubMed
  33. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  34. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  35. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  36. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  37. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  38. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  39. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  40. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  41. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  42. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  43. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  44. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  45. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  46. Wang H, et al. 2023. Nature. 615:339. PubMed
  47. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  48. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  49. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  50. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  51. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  52. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  53. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  54. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  55. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  56. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  57. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  58. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  59. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  60. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  61. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  62. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  63. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  64. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  65. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  66. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  67. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  68. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  69. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  70. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  71. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  72. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  73. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  74. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  75. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  76. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  77. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  78. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  79. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  80. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  81. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  82. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  83. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  84. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  85. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  86. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  87. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  88. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  89. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  90. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  91. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  92. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  93. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  94. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  95. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  96. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  97. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  98. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  99. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  100. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  101. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  102. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  103. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  104. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  105. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  106. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  107. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  108. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  109. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  110. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  111. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  112. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  113. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  114. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  115. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  116. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  117. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  118. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  119. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  120. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  121. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  122. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  123. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  124. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  125. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  126. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  127. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  128. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  129. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  130. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  131. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  132. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  133. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  134. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  135. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  136. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  137. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  138. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  139. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  140. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  141. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  142. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  143. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  144. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  145. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  146. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  147. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  148. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  149. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  150. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  151. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  152. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  153. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  154. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  155. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  156. Ma K, et al. 2022. iScience. 25:104347. PubMed
  157. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  158. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  159. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  160. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  161. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  162. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  163. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  164. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  165. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  166. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  167. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  168. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  169. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  170. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  171. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  172. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  173. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  174. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  175. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  176. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  177. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  178. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  179. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  180. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  181. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  182. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  183. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  184. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  185. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  186. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  187. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  188. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  189. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  190. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  191. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  192. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  193. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  194. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  195. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  196. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  197. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  198. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  199. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  200. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  201. Wang X, et al. 2022. Elife. 11:. PubMed
  202. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  203. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  204. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  205. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  206. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  207. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  208. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  209. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  210. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  211. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  212. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  213. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  214. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  215. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  216. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  217. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  218. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  219. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  220. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  221. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  222. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  223. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  224. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  225. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  226. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  227. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  228. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  229. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  230. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  231. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  232. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  233. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  234. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  235. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  236. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  237. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  238. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  239. Chan L, et al. 2022. Cells. 12: . PubMed
  240. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  241. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  242. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  243. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  244. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  245. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  246. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  247. Zander R, et al. 2022. Immunity. 55:475. PubMed
  248. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  249. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  250. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  251. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  252. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  253. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  254. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  255. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  256. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  257. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  258. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  259. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  260. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  261. Wang H, et al. 2023. Nature. 615:339. PubMed
  262. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  263. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  264. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  265. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  266. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  267. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  268. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  269. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  270. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  271. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  272. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  273. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  274. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  275. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  276. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  277. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  278. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  279. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  280. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  281. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  282. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  283. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  284. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  285. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  286. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  287. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  288. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  289. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  290. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  291. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  292. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  293. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  294. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  295. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  296. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  297. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  298. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  299. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  300. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  301. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  302. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  303. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  304. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  305. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  306. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  307. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  308. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  309. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  310. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  311. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  312. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  313. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  314. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  315. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  316. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  317. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  318. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  319. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  320. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  321. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  322. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  323. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  324. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  325. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  326. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  327. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  328. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  329. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  330. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  331. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  332. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  333. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  334. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  335. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  336. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  337. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  338. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  339. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  340. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  341. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  342. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  343. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  344. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  345. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  346. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  347. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  348. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  349. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  350. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  351. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  352. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  353. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  354. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  355. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  356. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  357. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  358. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  359. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  360. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  361. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  362. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  363. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  364. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  365. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  366. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  367. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  368. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  369. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  370. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  371. Ma K, et al. 2022. iScience. 25:104347. PubMed
  372. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  373. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  374. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  375. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  376. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  377. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  378. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  379. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  380. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  381. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  382. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  383. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  384. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  385. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  386. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  387. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  388. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  389. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  390. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  391. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  392. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  393. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  394. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  395. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  396. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  397. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  398. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  399. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  400. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  401. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  402. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  403. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  404. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  405. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  406. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  407. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  408. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  409. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  410. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  411. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  412. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  413. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  414. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  415. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  416. Wang X, et al. 2022. Elife. 11:. PubMed
  417. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  418. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  419. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  420. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  421. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  422. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  423. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  424. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  425. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  426. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  427. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  428. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  429. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  430. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 4    Revision Date: 07/25/2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixative, Paraformaldehyde
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420801 100 mL DKK351
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Fixation Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Fixation Buffer is used to fix cells prior to permeabilization using Permeabilization Wash Buffer (Cat. No. 421002). BioLegend's Fixation Buffer has been formulated with prescreened paraformaldehyde with low background, thus producing the greatest signal to noise ratio.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
This buffer solution should be stored between 2°C and 8°C.
Application

ICFC - Quality tested
ICC
Recommended Usage

For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website.
Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.

Application Notes

This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.

Application References
  1. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  2. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed
  3. Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed
  4. del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed
  5. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  6. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  7. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  8. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
Product Citations
  1. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  2. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  3. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  4. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  5. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  6. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  7. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  8. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  9. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  10. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  11. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  12. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  13. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  14. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  15. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  16. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  17. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  18. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  19. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  20. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  21. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  22. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  23. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  24. Chan L, et al. 2022. Cells. 12: . PubMed
  25. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  26. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  27. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  28. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  29. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  30. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  31. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  32. Zander R, et al. 2022. Immunity. 55:475. PubMed
  33. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  34. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  35. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  36. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  37. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  38. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  39. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  40. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  41. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  42. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  43. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  44. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  45. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  46. Wang H, et al. 2023. Nature. 615:339. PubMed
  47. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  48. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  49. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  50. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  51. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  52. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  53. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  54. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  55. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  56. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  57. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  58. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  59. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  60. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  61. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  62. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  63. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  64. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  65. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  66. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  67. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  68. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  69. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  70. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  71. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  72. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  73. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  74. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  75. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  76. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  77. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  78. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  79. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  80. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  81. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  82. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  83. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  84. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  85. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  86. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  87. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  88. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  89. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  90. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  91. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  92. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  93. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  94. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  95. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  96. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  97. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  98. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  99. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  100. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  101. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  102. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  103. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  104. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  105. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  106. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  107. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  108. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  109. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  110. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  111. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  112. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  113. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  114. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  115. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  116. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  117. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  118. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  119. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  120. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  121. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  122. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  123. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  124. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  125. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  126. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  127. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  128. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  129. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  130. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  131. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  132. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  133. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  134. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  135. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  136. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  137. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  138. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  139. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  140. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  141. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  142. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  143. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  144. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  145. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  146. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  147. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  148. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  149. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  150. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  151. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  152. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  153. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  154. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  155. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  156. Ma K, et al. 2022. iScience. 25:104347. PubMed
  157. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  158. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  159. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  160. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  161. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  162. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  163. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  164. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  165. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  166. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  167. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  168. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  169. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  170. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  171. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  172. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  173. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  174. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  175. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  176. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  177. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  178. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  179. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  180. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  181. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  182. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  183. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  184. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  185. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  186. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  187. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  188. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  189. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  190. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  191. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  192. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  193. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  194. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  195. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  196. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  197. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  198. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  199. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  200. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  201. Wang X, et al. 2022. Elife. 11:. PubMed
  202. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  203. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  204. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  205. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  206. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  207. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  208. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  209. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  210. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  211. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  212. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  213. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  214. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  215. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  216. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  217. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  218. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  219. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  220. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  221. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  222. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  223. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  224. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  225. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  226. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  227. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  228. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  229. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  230. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  231. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  232. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  233. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  234. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  235. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  236. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  237. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  238. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  239. Chan L, et al. 2022. Cells. 12: . PubMed
  240. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  241. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  242. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  243. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  244. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  245. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  246. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  247. Zander R, et al. 2022. Immunity. 55:475. PubMed
  248. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  249. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  250. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  251. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  252. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  253. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  254. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  255. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  256. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  257. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  258. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  259. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  260. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  261. Wang H, et al. 2023. Nature. 615:339. PubMed
  262. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  263. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  264. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  265. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  266. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  267. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  268. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  269. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  270. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  271. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  272. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  273. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  274. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  275. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  276. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  277. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  278. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  279. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  280. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  281. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  282. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  283. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  284. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  285. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  286. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  287. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  288. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  289. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  290. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  291. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  292. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  293. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  294. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  295. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  296. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  297. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  298. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  299. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  300. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  301. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  302. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  303. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  304. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  305. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  306. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  307. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  308. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  309. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  310. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  311. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  312. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  313. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  314. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  315. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  316. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  317. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  318. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  319. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  320. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  321. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  322. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  323. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  324. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  325. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  326. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  327. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  328. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  329. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  330. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  331. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  332. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  333. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  334. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  335. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  336. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  337. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  338. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  339. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  340. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  341. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  342. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  343. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  344. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  345. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  346. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  347. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  348. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  349. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  350. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  351. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  352. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  353. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  354. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  355. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  356. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  357. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  358. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  359. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  360. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  361. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  362. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  363. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  364. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  365. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  366. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  367. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  368. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  369. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  370. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  371. Ma K, et al. 2022. iScience. 25:104347. PubMed
  372. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  373. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  374. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  375. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  376. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  377. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  378. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  379. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  380. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  381. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  382. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  383. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  384. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  385. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  386. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  387. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  388. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  389. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  390. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  391. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  392. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  393. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  394. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  395. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  396. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  397. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  398. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  399. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  400. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  401. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  402. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  403. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  404. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  405. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  406. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  407. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  408. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  409. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  410. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  411. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  412. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  413. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  414. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  415. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  416. Wang X, et al. 2022. Elife. 11:. PubMed
  417. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  418. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  419. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  420. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  421. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  422. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  423. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  424. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  425. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  426. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  427. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  428. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  429. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  430. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA
Go To Top Version: 4    Revision Date: 07/25/2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account